VTAK News & Events

Catheter Precision announced a surge in hospital evaluations and approvals for its LockeT suture retention device. As the company enters the first quarter of 2026, it reports significant progress in domestic and international product adoption, driven by successful clinical outcomes and the device's ability to streamline hospital workflows. Following its highest recorded revenue for the month of January, and following its recent entry into several international markets, Catheter Precision has secured approval for evaluations at several additional influential high-volume centers throughout the Unites States. These evaluations are a critical precursor to long-term purchasing agreements, allowing clinical teams to validate LockeT's efficacy and additional adoption at affiliated hospitals within a network.

Catheter Precision announced receipt of a LockeT purchase order from Universitatsklinikum Frankfurt. This purchase order marks the official entry of LockeT into Germany. The purchase order includes the LockeT suture retention device. "Securing our first purchase order from a prestigious German university hospital is a definitive turning point for Catheter Precision," said David Jenkins, CEO of Catheter Precision. "Germany represents the most significant healthcare market in Europe, with the German Electrophysiology Devices Market size valued at over $900 million in 2024. This partnership validates the clinical value of our technology and serves as the cornerstone of our expansion strategy in the region."

Catheter Precision announced receipt of a VIVO purchase order from University Clinical Center Ljubljana, a hospital in Slovenia. This expands Catheter Precision's global sales footprint to 15 countries. "We are thrilled that we are growing our global sales footprint and now have products in 15 countries," said David Jenkins, CEO of Catheter Precision. "Continued expansion validates that our products, both VIVO and LockeT, provide benefits to physicians by solving real-world challenges in EP Lab workflows and that physicians are finding our products are easy to use and effective for streamlining EP procedures and recovery after the procedures."